DistantNews
Support us
Health Canada Wins Injunction Against Unauthorized Peptide Seller
๐Ÿ‡จ๐Ÿ‡ฆ Canada /Health & Science

Health Canada Wins Injunction Against Unauthorized Peptide Seller

From Global News · () English

Translated from English, summarized and contextualized by DistantNews.

At a glance

News Official statement Outcome reported
  • Health Canada has obtained a permanent injunction against Quebec-based online retailer Canlab Research for selling unauthorized injectable peptides.
  • The company promoted these products with unproven health claims, despite previous enforcement actions and warnings about serious health risks.
  • The injunction prohibits Canlab Research from manufacturing, selling, or advertising unauthorized peptides in Canada.

Health Canada has successfully secured a permanent injunction against Canlab Research, an online retailer based in Quebec, effectively barring the company from selling unauthorized injectable peptides across Canada. The federal health agency stated that Canlab Research had been distributing these unapproved peptide drugs through various websites, often making unsubstantiated health claims.

selling unauthorized peptide drugs on various websites and promoting them with many unproven health claims, despite repeated enforcement actions by Health Canada.

โ€” Health CanadaDescribing the actions of Canlab Research.

This action follows repeated enforcement efforts by Health Canada. In December 2023, consumers were warned about the significant health risks associated with Canlab Research's products. Health Canada had previously issued a ministerial order directing the company to cease advertising and selling unauthorized health products due to the potential danger to Canadians.

serious health risks posed by these products

โ€” Health CanadaReason for urging consumers not to buy from Canlab Research in December 2023.

The new injunction imposes strict prohibitions on Canlab Research and its associates. They are forbidden from manufacturing, testing, distributing, or selling unauthorized injectable peptides. Furthermore, they cannot assist others in these activities or advertise the products through any online platform accessible within Canada.

Under the injunction, Canlab Research and its representatives cannot manufacture, test, distribute or sell unauthorized injectable peptides, nor can it assist others in doing the same. It also cannot advertise or assist others in advertising these products, including through any website or social media platform accessible with a Canadian Internet Protocol (IP) address.

โ€” Health CanadaDetailing the terms of the permanent injunction.

Injectable peptides affect bodily functions and are commonly marketed for bodybuilding, anti-aging, and athletic performance enhancement. In Canada, these are regulated as prescription drugs and require Health Canada authorization before sale. The agency previously warned consumers in April about the risks of injecting peptides bought online, noting potential side effects such as hormonal imbalance, mood swings, liver or kidney damage, blood clots, and even cancerous tumor growth.

change how your body works and are often promoted online and on social media for โ€˜anti-aging, weight loss, bodybuilding, athletic performance, injury recovery, sleep, mental focus, or general wellness.โ€™

โ€” Health CanadaDescribing the purported uses of peptides.
DistantNews Editorial

Originally published by Global News in English. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.